Procarbazine in Dogs & Cats
Generic: Procarbazine
Procarbazine is an oral chemotherapy drug used to treat certain types of cancer in animals, primarily by interfering with DNA and RNA synthesis.
This medication is intended for dogs and cats.
Overview
Procarbazine, also known by the brand name Matulane, is an alkylating agent that belongs to a class of drugs called antineoplastics, which are used to treat cancer. It is a cytotoxic drug, meaning it kills cells, and is typically administered orally. In veterinary medicine, procarbazine is often used as part of a multi-modal treatment plan for various cancers, sometimes in combination with other chemotherapy agents like cyclophosphamide or radiation therapy. Its use is generally reserved for cases where other treatments have not been successful or when a specific type of cancer is known to be responsive to this drug. It is important to note that procarbazine is a potent medication that requires careful monitoring by a veterinarian due to its potential for significant side effects.
While not as commonly used as some other chemotherapy drugs in companion animals, procarbazine has found a niche in treating specific neoplastic conditions. Its effectiveness stems from its ability to alkylate DNA and interfere with various cellular processes essential for cancer cell replication and survival. This mechanism of action makes it a valuable tool in the oncologist's arsenal, particularly when dealing with certain lymphoid malignancies or brain tumors. The decision to use procarbazine is always based on a thorough diagnosis, staging of the cancer, and consideration of the individual animal's health status and potential for tolerating the treatment. Other chemotherapy options available for veterinary use include lomustine (CCNU), mitoxantrone, and vinblastine, among others. Veterinary oncologists will tailor treatment protocols to maximize efficacy while minimizing adverse events.
Procarbazine's role in veterinary oncology is often as an adjunct or salvage therapy. It may be employed when cancers become resistant to other treatments or to achieve a more complete remission. The drug's ability to cross the blood-brain barrier can make it a consideration for certain central nervous system tumors. However, its use requires a deep understanding of its pharmacokinetics, pharmacodynamics, and potential toxicities in different species. Close collaboration between the veterinarian, the pet owner, and potentially a veterinary specialist is crucial for successful management when procarbazine is part of the therapeutic strategy. Newer targeted therapies like masitinib and toceranib (Palladia) are also available for certain cancers, offering different approaches to treatment.
What It Treats
- Lymphoma: Particularly in cases where standard protocols have failed or in specific subtypes of lymphoma.
- Brain Tumors (Gliomas): Due to its ability to cross the blood-brain barrier, it may be used for certain intracranial neoplasms.
- Mast Cell Tumors: Sometimes used as part of a combination chemotherapy protocol for advanced or aggressive mast cell disease.
- Other Neoplasms: May be considered for various other cancers unresponsive to initial treatments, often as a salvage therapy.
How It Works
Procarbazine is a prodrug, meaning it must be metabolized in the body to become active. Once activated, it exerts its anti-cancer effects primarily through alkylation of DNA. Alkylating agents add an alkyl group to DNA bases, which disrupts the DNA's structure and function. This disruption can lead to DNA strand breaks, cross-linking of DNA strands, and interference with DNA replication and transcription, ultimately triggering programmed cell death (apoptosis) in rapidly dividing cancer cells. Beyond direct DNA alkylation, procarbazine also interferes with RNA and protein synthesis. It can inhibit enzymes involved in nucleotide synthesis, further hindering the cancer cells' ability to repair DNA or produce essential proteins for survival and proliferation. This multi-faceted approach to cellular disruption makes it effective against a range of neoplastic cells, although it also contributes to its toxicity profile as it can affect healthy, rapidly dividing cells in the body.
Dosage
Dosage of procarbazine is highly individualized and depends on the specific cancer being treated, the animal's species, breed, weight, overall health, and response to therapy. It is crucial to follow the exact dosing schedule and duration prescribed by your veterinarian. Doses are often calculated on a mg/m² or mg/kg basis and may be given daily for a period, followed by rest days or weeks. Never adjust the dose or stop treatment without consulting your veterinarian, as this can impact the effectiveness of the treatment and potentially lead to drug resistance.
Administration
Procarbazine is typically administered orally, in capsule form. The capsules should be given whole and not crushed or opened, as this can increase exposure to the active drug and potentially cause irritation or increased absorption. The medication is usually given with food to help minimize gastrointestinal upset. Your veterinarian will provide specific instructions on how and when to administer the medication, including any necessary dose adjustments or breaks in treatment.
Storage
Procarbazine capsules should be stored at room temperature, typically between 68°F and 77°F (20°C to 25°C), protected from light and moisture. They should be kept in their original container. Avoid storing them in the bathroom or kitchen where temperature and humidity can fluctuate. It is essential to store procarbazine securely out of reach of children and pets, as it is a cytotoxic medication.
Contraindications
Procarbazine should not be used in animals with known hypersensitivity to the drug or its components. It is generally contraindicated in patients with severe bone marrow suppression, as it can exacerbate this condition. Due to its potential for liver toxicity, caution should be exercised in animals with pre-existing liver disease. Pregnant or lactating animals should also not be treated with procarbazine, as it can cause developmental abnormalities in fetuses and may be excreted in milk, potentially harming nursing young. Furthermore, procarbazine can interact with certain other medications and foods (containing high levels of tyramine). These interactions can lead to serious adverse effects, such as hypertensive crisis. Therefore, it is essential to inform your veterinarian of all medications, supplements, and dietary restrictions your pet is currently undergoing before initiating procarbazine therapy. Careful consideration of the animal's overall health status, including kidney function, is also necessary, as impaired kidney function may affect drug clearance.
Interactions
Procarbazine can interact with several types of medications. It is a monoamine oxidase (MAO) inhibitor, which means it can prevent the breakdown of certain neurotransmitters like serotonin and norepinephrine. This effect can lead to a dangerous increase in blood pressure (hypertensive crisis) if combined with sympathomimetic drugs (e.g., pseudoephedrine) or certain antidepressants. It also interacts with foods high in tyramine (aged cheeses, cured meats, certain beers and wines), which can also precipitate hypertensive crisis. Therefore, strict dietary restrictions are often recommended during procarbazine therapy. Additionally, concurrent use with other drugs that cause myelosuppression, such as [chlorambucil](/medications/chlorambucil-in-dogs-and-cats), [methotrexate](/medications/methotrexate-in-dogs-and-cats), or certain injectable chemotherapy agents, can lead to additive bone marrow suppression. Barbiturates may also have altered effects when used with procarbazine. It is imperative that veterinarians are provided with a complete list of all medications, including over-the-counter drugs and supplements, your pet is receiving to assess potential interactions. This comprehensive list may also include [vinorelbine](/medications/vinorelbine-in-dogs-and-cats) and [vincristine](/medications/vincristine-in-dogs-and-cats).
Side Effects
- Common Side Effects:
- Gastrointestinal upset: Vomiting, diarrhea, decreased appetite.
- Lethargy: Reduced activity and energy levels.
- Myelosuppression: A decrease in white blood cells (leukopenia), red blood cells (anemia), and platelets (thrombocytopenia), leading to increased risk of infection, fatigue, and bleeding. This is often the dose-limiting toxicity.
- Hair loss (alopecia): More common in some species or breeds.
- Skin reactions: Rashes or itching.
- Serious Side Effects:
- Severe myelosuppression: Requiring transfusions or hospitalization.
- Hepatotoxicity: Liver enzyme elevations or liver damage.
- Neurological signs: Tremors, seizures, coordination problems (rare).
- Hypersensitivity reactions: Allergic reactions.
Sources & References
Frequently Asked Questions
This information is educational only and not a substitute for professional veterinary advice. Always consult a licensed veterinarian before starting or changing any medication.
